Trial Profile

A Phase 1, Open-Label, Multiple Dose Study to Assess the Pharmacokinetics, Safety, Tolerability, and Food Effect of MRX1 in Healthy Adults

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 25 Jun 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Cannabidiol (Primary)
Indications Neuropathic pain
Focus Pharmacokinetics

Most Recent Events

17 Jun 2026 According to an Ananda Pharma media release, the Company's Phase 1 pharmacokinetic study has now been completed, yielding highly encouraging data that confirms favourable safety and tolerability and dose selection for future clinical studies.Phase 2 dosing on track to start H2 2026.
17 Jun 2026 Results presented in an Ananda Pharma Media Release.
04 Feb 2026 Status changed from recruiting to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com